Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

ClinicalTrials.gov ID: NCT01782989

Public ClinicalTrials.gov record NCT01782989. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 1:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective, randomized study to evaluate the efficacy and safety of ORACEA® in the treatment of geographic atrophy due to dry age-related macular degeneration (AMD).

Study identification

NCT ID
NCT01782989
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Paul Yates, MD, PhD
Other
Enrollment
286 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2013
Primary completion
Oct 31, 2020
Completion
Oct 31, 2020
Last update posted
Nov 3, 2022

2013 – 2020

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
34
Facility City State ZIP Site status
Macula and Retina Institute Glendale California 91203
Retina Consultants of San Diego Poway California 92064
Colorado Retina Associates, PC Golden Colorado 80401
Eldorado Retina Associates Louisville Colorado 80027
New England Retina Associates Hamden Connecticut 06518
George Washington University Washington D.C. District of Columbia 20037
Retina Group of Florida Fort Lauderdale Florida 33308
Medical Center Eye Institute / Gulf Region Clinical Research Institute Pensacola Florida 32514
Retina Vitreous Associates of Florida St. Petersburg Florida 33703
Gailey Eye Clinic Bloomington Illinois 61704
Retina Associates of Kentucky Lexington Kentucky 40509
New England Eye Center at Tufts Medical Center Boston Massachusetts 02111
Harvard Vanguard Medical Associates Boston Massachusetts 02215
Vitreo-Retinal Associates Worcester Massachusetts 01605
Retina Specialists of Michigan Grand Rapids Michigan 49525
Retina Center Minneapolis Minnesota 55404
Lifelong Vision Foundation Chesterfield Missouri 63017
Delaware Valley Retina Associates Lawrenceville New Jersey 08648
Retinal and Ophthalmic Consultants Northfield New Jersey 08225
New Jersey Retina Toms River New Jersey 08755
MaculaCare New York New York 10021
Vitreous Retina Macula Consultants of New York New York New York 10022
New York Eye and Ear New York New York
Retina Associates of Western New York Rochester New York 14620
Cole Eye Institute / Cleveland Clinic Foundation Cleveland Ohio 44195
Oregon Retina Eugene Oregon 97401
Pennsylvania Retina Specialists, PC Camp Hill Pennsylvania 17011
Mid Atlantic Retina / Wills Eye Institute Philadelphia Pennsylvania 19107
University of Pittsburgh Eye Center Pittsburgh Pennsylvania 15213
Associates in Ophthalmology, Ltd West Mifflin Pennsylvania 15122
Retina Research Institute of Texas Abilene Texas 79606
Brian B. Berger, MD and Associates / Retina Research Center Austin Texas 78705
Retina Associates of South Texas San Antonio Texas 78240
University of Virginia Charlottesville Virginia 22903
Wagner Macula & Retina Center Virginia Beach Virginia 23462
Virginia Retina Center Warrenton Virginia 20186
Retina Cosultants Charleston West Virginia 25301

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01782989, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2022 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01782989 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →